Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 7/2008

01.07.2008 | original artilce

The Resection of the Azygos Vein — Necessary or Redundant Extension of Transthoracic Esophagectomy?

verfasst von: W. Schröder, D. Vallböhmer, M. Bludau, A. Banczyk, C. Gutschow, A. H. Hölscher

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Due to the increasing use of minimally invasive techniques, some authors have questioned the necessity to dissect the azygos vein as part of the en-bloc esophagectomy in patients with esophageal cancer. This study investigates the nodal clearance associated with resection of the azygos vein. Ninety-two patients with esophageal carcinoma were included in this prospective analysis. In all patients, a standard transthoracic en-bloc esophagectomy was performed including the resection of the azygos vein from the superior vena cava to the level of the diaphragm. After resection, the azygos vein with its adjacent connective tissue was separated from the tubular esophagus. The separated azygos vein specimen was histopathologically examined for the presence of lymph nodes (LN) and possible nodal metastasis. A total of 2,778 LN with a mean of 30.2 LN for each patient were resected. In 60 patients, 216 of 1,666 mediastinal LN (13.0%) were located along the azygos vein. Seven of 39 pN1 patients (17.9%) had LN metastases in the separated azygos vein specimen. In these seven patients, a total of 23 metastatic nodes were detected along the azygos vein. LN metastases along the azygos vein are too frequent to neglect their existence. Therefore, standard en-bloc esophagectomy including dissection of the azygos vein should not be abandoned irrespective of the surgical approach.
Literatur
1.
Zurück zum Zitat Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous cell esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225–232.PubMedCrossRef Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous cell esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225–232.PubMedCrossRef
2.
Zurück zum Zitat Siewert JR, Stein HJ, Feith M, Bruecher BLDM, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the western world. Ann Surg 2001;234:360.PubMedCrossRef Siewert JR, Stein HJ, Feith M, Bruecher BLDM, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the western world. Ann Surg 2001;234:360.PubMedCrossRef
3.
Zurück zum Zitat Hölscher AH, Schröder W, Bollschweiler E, Beckurts KTE, Schneider PM. How safe is high intrathoracic esophagogastrostomy? Chirurg 2003;74:726–733.PubMedCrossRef Hölscher AH, Schröder W, Bollschweiler E, Beckurts KTE, Schneider PM. How safe is high intrathoracic esophagogastrostomy? Chirurg 2003;74:726–733.PubMedCrossRef
4.
Zurück zum Zitat Lerut T, Nafteux P, Moons J, Coosemanns W, Decker G, de Lyn P, van Raemdonck D, Ectors N. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease free survival and outcome. Ann Surg 2004;240:962–974.PubMedCrossRef Lerut T, Nafteux P, Moons J, Coosemanns W, Decker G, de Lyn P, van Raemdonck D, Ectors N. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease free survival and outcome. Ann Surg 2004;240:962–974.PubMedCrossRef
5.
Zurück zum Zitat Hulscher JB, van Sandick JW, de Boer AGEM, Wijnhoven BPL, Tijssen JGP, Fockens P, Stalmeier PFM, Ten Kate FJW, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJB. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662–1669.PubMedCrossRef Hulscher JB, van Sandick JW, de Boer AGEM, Wijnhoven BPL, Tijssen JGP, Fockens P, Stalmeier PFM, Ten Kate FJW, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJB. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662–1669.PubMedCrossRef
6.
Zurück zum Zitat Omloo JMT, Lagarde SM, Hulscher JBF, Reitsma JB, Fockens P, van Dekken H, ten Kate FJW, Obertop H, Tilanus HW, van Lanschot JJB. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Five-year survival of a randomized clinical trial. Ann Surg 2007;246:992–1001.PubMedCrossRef Omloo JMT, Lagarde SM, Hulscher JBF, Reitsma JB, Fockens P, van Dekken H, ten Kate FJW, Obertop H, Tilanus HW, van Lanschot JJB. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Five-year survival of a randomized clinical trial. Ann Surg 2007;246:992–1001.PubMedCrossRef
7.
Zurück zum Zitat Luketich JD, Alvelo-Rivera M, Buenaventura O, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernanando HC. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003;238:486–495.PubMed Luketich JD, Alvelo-Rivera M, Buenaventura O, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernanando HC. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003;238:486–495.PubMed
8.
Zurück zum Zitat Osugi H, Takemura M, Higashino M et al. A comparison of videoassisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 2003;90:108–113.PubMedCrossRef Osugi H, Takemura M, Higashino M et al. A comparison of videoassisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 2003;90:108–113.PubMedCrossRef
9.
Zurück zum Zitat Yamamoto S, Kawahara K, Maekawa T, Shiraishi MD, Shirakusa T. Minimally invasive esophagectomy for stage I and II esophageal cancer. Ann Thorac Surg 2005;80:2070–2075.PubMedCrossRef Yamamoto S, Kawahara K, Maekawa T, Shiraishi MD, Shirakusa T. Minimally invasive esophagectomy for stage I and II esophageal cancer. Ann Thorac Surg 2005;80:2070–2075.PubMedCrossRef
10.
Zurück zum Zitat Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of outcome between open and minimally invasive esophagectomy. Ann Surg 2007;245:232–240.PubMedCrossRef Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of outcome between open and minimally invasive esophagectomy. Ann Surg 2007;245:232–240.PubMedCrossRef
11.
Zurück zum Zitat Boone J, Schipper MEI, Bleys RLAW, Rinkes IHM, van Hillegersberg R. The effect of azygos vein preservation on mediastinal lymph node harvesting in thoracic esophago-lymphadenectomy. Dis Esoph 2007 (in press). DOI 10.1111/j.1442–2050.2007.00760.x. Boone J, Schipper MEI, Bleys RLAW, Rinkes IHM, van Hillegersberg R. The effect of azygos vein preservation on mediastinal lymph node harvesting in thoracic esophago-lymphadenectomy. Dis Esoph 2007 (in press). DOI 10.​1111/​j.​1442–2050.​2007.​00760.​x.
12.
Zurück zum Zitat Schneider PM, Baldus SE, Metzger R, Hölscher AH. Histomorphologic tumour regression and lymph node metastasis determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response prediction. Ann Surg 2005;242:684–692.PubMedCrossRef Schneider PM, Baldus SE, Metzger R, Hölscher AH. Histomorphologic tumour regression and lymph node metastasis determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response prediction. Ann Surg 2005;242:684–692.PubMedCrossRef
13.
Zurück zum Zitat Hölscher AH, Schneider PM, Gutschow C, Schröder W. Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 2007;245(2):241–246.PubMedCrossRef Hölscher AH, Schneider PM, Gutschow C, Schröder W. Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 2007;245(2):241–246.PubMedCrossRef
14.
Zurück zum Zitat Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer 1998;1:10–24.PubMedCrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer 1998;1:10–24.PubMedCrossRef
15.
Zurück zum Zitat Japanese Society for Esophageal Disease. Guidelines for clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg 1976;6:69–78.CrossRef Japanese Society for Esophageal Disease. Guidelines for clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg 1976;6:69–78.CrossRef
16.
Zurück zum Zitat Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. New York: Wiley, 1997. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. New York: Wiley, 1997.
17.
Zurück zum Zitat Schröder W, Baldus S, Mönig SP, Zirbes TK, Beckurts TKE, Hölscher AH. Lesser curvature lymph node metastases with esophageal carcinoma: implications for gastroplasty. World J Surg 2001;25:1125–1128.PubMed Schröder W, Baldus S, Mönig SP, Zirbes TK, Beckurts TKE, Hölscher AH. Lesser curvature lymph node metastases with esophageal carcinoma: implications for gastroplasty. World J Surg 2001;25:1125–1128.PubMed
18.
Zurück zum Zitat Dresner Sm, Lamb PJ, Bennet MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103–109.PubMedCrossRef Dresner Sm, Lamb PJ, Bennet MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103–109.PubMedCrossRef
19.
Zurück zum Zitat Schröder W, Mönig SP, Baldus SE, Gutschow C, Schneider PM, Hölscher AH. Frequency of nodal metastases to the upper mediastinum in Barrett’s cancer. Ann Surg Oncol 2002;9:807–811.PubMed Schröder W, Mönig SP, Baldus SE, Gutschow C, Schneider PM, Hölscher AH. Frequency of nodal metastases to the upper mediastinum in Barrett’s cancer. Ann Surg Oncol 2002;9:807–811.PubMed
20.
Zurück zum Zitat Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177–183.PubMedCrossRef Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177–183.PubMedCrossRef
21.
Zurück zum Zitat Hulscher JBF, van Sandick JW, Offerahus GJA, Tilanus HW, Obertop H, van Lanschot JJB. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia. Br J Surg 2001;88:715–719.PubMedCrossRef Hulscher JBF, van Sandick JW, Offerahus GJA, Tilanus HW, Obertop H, van Lanschot JJB. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia. Br J Surg 2001;88:715–719.PubMedCrossRef
22.
Zurück zum Zitat Schröder W, Baldus SE, Mönig SP, Beckurts KTE, Dienes HP, Hölscher AH. Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg 2002;26:584–587.PubMedCrossRef Schröder W, Baldus SE, Mönig SP, Beckurts KTE, Dienes HP, Hölscher AH. Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg 2002;26:584–587.PubMedCrossRef
23.
Zurück zum Zitat Orringer MB, Marshall B, Jannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999;230:392–403.PubMedCrossRef Orringer MB, Marshall B, Jannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999;230:392–403.PubMedCrossRef
24.
Zurück zum Zitat Zantl N, Stein HJ, Brücher BL, Bartels H, Siewert JR. Ischemic spinal cord syndrome after transthoracic esophagectomy: two cases of a rare neurologic complication. Dis Esophagus 2000;13:328–332.PubMedCrossRef Zantl N, Stein HJ, Brücher BL, Bartels H, Siewert JR. Ischemic spinal cord syndrome after transthoracic esophagectomy: two cases of a rare neurologic complication. Dis Esophagus 2000;13:328–332.PubMedCrossRef
25.
Zurück zum Zitat Lin FCF, Russel H, Ferguson MK. Strangulation of reconstructive gastric tube by the azygos vein. Ann Thorac Surg 2006;82:8–10.CrossRef Lin FCF, Russel H, Ferguson MK. Strangulation of reconstructive gastric tube by the azygos vein. Ann Thorac Surg 2006;82:8–10.CrossRef
Metadaten
Titel
The Resection of the Azygos Vein — Necessary or Redundant Extension of Transthoracic Esophagectomy?
verfasst von
W. Schröder
D. Vallböhmer
M. Bludau
A. Banczyk
C. Gutschow
A. H. Hölscher
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 7/2008
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-008-0487-x

Weitere Artikel der Ausgabe 7/2008

Journal of Gastrointestinal Surgery 7/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.